» Articles » PMID: 35335215

Evaluation of Two Novel Hydantoin Derivatives Using Reconstructed Human Skin Model Episkin: Perspectives for Application As Potential Sunscreen Agents

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Mar 26
PMID 35335215
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to assess two novel 5-arylideneimidazolidine-2,4-dione (hydantoin) derivatives (JH3 and JH10) demonstrating photoprotective activity using the reconstructed human skin model Episkin. The skin permeability, irritation, and phototoxicity of the compounds was evaluated in vitro. Moreover, the in vitro genotoxicity and human metabolism of both compounds was studied. For skin permeation and irritation experiments, the test compounds were incorporated into a formulation. It was shown that JH3 and JH10 display no skin irritation and no phototoxicity. Both compounds did not markedly enhance the frequency of micronuclei in CHO-K1 cells in the micronucleus assay. Preliminary in vitro studies with liver microsomes demonstrated that hydrolysis appears to constitute their important metabolic pathway. Episkin permeability experiments showed that JH3 permeability was lower than or close to currently used UV filters, whereas JH10 had the potential to permeate the skin. Therefore, a restriction of this compound permeability should be obtained by choosing the right vehicle or by optimizing it, which should be addressed in future studies.

References
1.
Leth-Petersen S, Bundgaard C, Hansen M, Carnerup M, Kehler J, Kristensen J . Correlating the metabolic stability of psychedelic 5-HT₂A agonists with anecdotal reports of human oral bioavailability. Neurochem Res. 2014; 39(10):2018-23. DOI: 10.1007/s11064-014-1253-y. View

2.
Janjua N, Mogensen B, Andersson A, Petersen J, Henriksen M, Skakkebaek N . Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol. 2004; 123(1):57-61. DOI: 10.1111/j.0022-202X.2004.22725.x. View

3.
Kirsch-Volders M, Vanhauwaert A, Eichenlaub-Ritter U, Decordier I . Indirect mechanisms of genotoxicity. Toxicol Lett. 2003; 140-141:63-74. DOI: 10.1016/s0378-4274(02)00498-8. View

4.
Sloczynska K, Panczyk K, Waszkielewicz A, Marona H, Pekala E . In vitro mutagenic, antimutagenic, and antioxidant activities evaluation and biotransformation of some bioactive 4-substituted 1-(2-methoxyphenyl)piperazine derivatives. J Biochem Mol Toxicol. 2016; 30(12):593-601. DOI: 10.1002/jbt.21826. View

5.
Fabbrocini G, Triassi M, Mauriello M, Torre G, Annunziata M, De Vita V . Epidemiology of skin cancer: role of some environmental factors. Cancers (Basel). 2013; 2(4):1980-9. PMC: 3840456. DOI: 10.3390/cancers2041980. View